Close

Ratings by Benchmark (Bruce Jackson)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
4/19/2024 Cardio Diagnostics Holdings, Inc. CDIO Maintain Speculative Buy
(N/A)
 
 
  Details
4/15/2024 Tenon Medical Inc. TNON Maintain Speculative Buy
(N/A)
 
 
  Details
4/8/2024 Know Labs KNW New Coverage Speculative Buy
(N/A)
0.64
(0.65)
1.56% Details
3/13/2024 Tenon Medical Inc. TNON Maintain Speculative Buy
(N/A)
 
 
  Details
1/2/2024 Exact Sciences EXAS Upgrade Buy
(Hold)
73.98
(50.38)
-31.9% Details
11/15/2023 Tenon Medical Inc. TNON Maintain Speculative Buy
(N/A)
 
 
  Details
11/14/2023 The Beauty Health Company SKIN Downgrade Hold
(Buy)
3.90
(2.74)
-29.74% Details
9/21/2023 Seelos Therapeutics SEEL Maintain Speculative Buy
(N/A)
 
 
  Details
9/15/2023 STAAR Surgical STAA Downgrade Hold
(Buy)
42.87
(42.70)
-0.4% Details
8/24/2023 OncoCyte Corp OCX Maintain Speculative Buy
(N/A)
 
 
  Details
8/9/2023 Neogenomics NEO Maintain Buy
(N/A)
 
 
  Details
8/2/2023 Exact Sciences EXAS Downgrade Hold
(Buy)
96.44
(73.98)
-23.29% Details
7/26/2023 OncoCyte Corp OCX Maintain Speculative Buy
(N/A)
 
 
  Details
7/21/2023 CytoMed Therapeutics GDTC New Coverage Speculative Buy
(N/A)
3.85
(2.12)
-44.94% Details
6/30/2023 Clene, Inc. CLNN Maintain Buy
(N/A)
 
 
  Details
6/22/2023 Exact Sciences EXAS Maintain Buy
(N/A)
 
 
  Details
6/8/2023 Reviva Pharmaceuticals RVPH New Coverage Speculative Buy
(N/A)
7.16
(1.67)
-76.68% Details
5/10/2023 Exact Sciences EXAS Maintain Buy
(N/A)
 
 
  Details
5/4/2023 STAAR Surgical STAA Maintain Buy
(N/A)
 
 
  Details
4/26/2023 Harvard Bioscience Inc. HBIO Maintain Speculative Buy
(N/A)
 
 
  Details
4/10/2023 Clene, Inc. CLNN Maintain Buy
(N/A)
 
 
  Details
3/24/2023 Seelos Therapeutics SEEL Maintain Speculative Buy
(N/A)
 
 
  Details
3/15/2023 Exact Sciences EXAS Maintain Buy
(N/A)
 
 
  Details
3/10/2023 Harvard Bioscience Inc. HBIO Maintain Speculative Buy
(N/A)
 
 
  Details
3/10/2023 Harvard Bioscience Inc. HBIO Upgrade Buy
(Speculative Buy)
2.66
(3.37)
26.69% Details
2/24/2023 Neogenomics NEO Upgrade Buy
(Hold)
16.63
(14.80)
-11% Details
2/1/2023 STAAR Surgical STAA Maintain Buy
(N/A)
 
 
  Details
2/1/2023 VolitionRX VNRX Downgrade Hold
(Buy)
2.47
(0.77)
-68.83% Details
1/10/2023 STAAR Surgical STAA Maintain Buy
(N/A)
 
 
  Details
12/19/2022 OncoCyte Corp OCX Maintain Speculative Buy
(N/A)
 
 
  Details
11/23/2022 Orgenesis ORGS Maintain Buy
(N/A)
 
 
  Details
11/21/2022 Hoth Therapeutics HOTH Maintain Speculative Buy
(N/A)
 
 
  Details
11/16/2022 OncoCyte Corp OCX Maintain Speculative Buy
(N/A)
 
 
  Details
11/10/2022 Harvard Bioscience Inc. HBIO Maintain Speculative Buy
(N/A)
 
 
  Details
11/3/2022 STAAR Surgical STAA Maintain Buy
(N/A)
 
 
  Details
11/1/2022 Cardio Diagnostics Holdings, Inc. CDIO Maintain Speculative Buy
(N/A)
 
 
  Details
8/26/2022 Neogenomics NEO Downgrade Hold
(Buy)
11.70
(14.80)
26.5% Details
8/11/2022 STAAR Surgical STAA Maintain Buy
(N/A)
 
 
  Details
8/8/2022 Heart Test Laboratories Inc. HSCS New Coverage Speculative Buy
(N/A)
2.12
(6.97)
228.77% Details
8/3/2022 Exact Sciences EXAS Maintain Buy
(N/A)
 
 
  Details
7/19/2022 Invitae Corporation NVTA Downgrade Hold
(Buy)
2.67
(0.02)
-99.25% Details
6/21/2022 Tenon Medical Inc. TNON New Coverage Speculative Buy
(N/A)
2.16
(0.85)
-60.65% Details
5/27/2022 Hoth Therapeutics HOTH Maintain Speculative Buy
(N/A)
 
 
  Details
5/17/2022 OncoCyte Corp OCX Maintain Speculative Buy
(N/A)
 
 
  Details
3/28/2022 STAAR Surgical STAA Upgrade Buy
(Neutral)
72.95
(42.70)
-41.47% Details
3/22/2022 The Beauty Health Company SKIN Maintain Buy
(N/A)
 
 
  Details
3/14/2022 The Beauty Health Company SKIN Maintain Buy
(N/A)
 
 
  Details
3/2/2022 Exact Sciences EXAS Maintain Buy
(N/A)
 
 
  Details
8/26/2021 Neogenomics NEO Maintain Buy
(N/A)
 
 
  Details
8/4/2021 Invitae Corporation NVTA Upgrade Buy
(Hold)
28.50
(0.02)
-99.93% Details
7/20/2021 Alpha Healthcare Acquisition Corp. AHAC New Coverage Buy
(N/A)
9.97
(10.96)
9.93% Details
6/28/2021 The Beauty Health Company SKIN Maintain Buy
(N/A)
 
 
  Details
3/25/2021 Neogenomics NEO Maintain Buy
(N/A)
 
 
  Details
3/18/2021 Vesper Healthcare VSPR New Coverage Buy
(N/A)
11.22
(12.49)
11.32% Details
3/17/2021 OncoCyte Corp OCX Maintain Speculative Buy
(N/A)
 
 
  Details
3/9/2021 Seelos Therapeutics SEEL Maintain Buy
(N/A)
 
 
  Details
2/5/2021 Neogenomics NEO Maintain Buy
(N/A)
 
 
  Details
1/19/2021 STAAR Surgical STAA Downgrade Hold
(Buy)
90.99
(42.70)
-53.07% Details
1/7/2021 Harvard Bioscience Inc. HBIO Upgrade Buy
(Speculative Buy)
4.27
(3.37)
-21.08% Details
1/7/2021 OncoCyte Corp OCX Upgrade Buy
(Speculative Buy)
2.53
(2.93)
15.81% Details
7/1/2020 Invitae Corporation NVTA Downgrade Hold
(Buy)
30.29
(0.02)
-99.93% Details
6/17/2020 Chembio Diagnostics CEMI Downgrade Hold
(Buy)
9.93
(0.46)
-95.37% Details
4/2/2020 Flexion Therapeutics FLXN Maintain Buy
(N/A)
 
 
  Details
3/20/2020 LHC Group LHCG Maintain Buy
(N/A)
 
 
  Details
3/4/2020 Chembio Diagnostics CEMI Maintain Speculative Buy
(N/A)
 
 
  Details
2/28/2020 Neogenomics NEO Maintain Buy
(N/A)
 
 
  Details
12/27/2019 Flexion Therapeutics FLXN Maintain Buy
(N/A)
 
 
  Details
12/9/2019 Harvard Bioscience Inc. HBIO Downgrade Speculative Sell
(Buy)
2.94
(3.37)
14.63% Details
11/20/2019 Biofrontera AG BFRA Maintain Buy
(N/A)
 
 
  Details
11/19/2019 STAAR Surgical STAA Maintain Buy
(N/A)
 
 
  Details
10/15/2019 Hoth Therapeutics HOTH New Coverage Speculative Buy
(N/A)
4.24
(1.18)
-72.17% Details
9/26/2019 Orgenesis ORGS New Coverage Speculative Sell
(N/A)
4.20
(0.55)
-86.9% Details
9/23/2019 Exact Sciences EXAS Upgrade Buy
(Hold)
103.97
(50.38)
-51.54% Details
7/31/2019 Neogenomics NEO Maintain Buy
(N/A)
 
 
  Details
5/9/2019 Flexion Therapeutics FLXN Upgrade Buy
(Hold)
10.24
(9.12)
-10.94% Details
1/4/2019 Flexion Therapeutics FLXN Downgrade Hold
(Buy)
12.46
(10.24)
-17.82% Details
11/1/2018 Neogenomics NEO Maintain Buy
(N/A)
 
 
  Details
9/5/2018 Exact Sciences EXAS New Coverage Hold
(N/A)
77.60
(103.97)
33.98% Details